Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World Results

The current strategies for the treatment of multiple myeloma (MM) have improved, thanks to effective drug classes and combination therapies, for both the upfront and relapsed settings. Clinical trials for newly diagnosed transplant-ineligible patients led to the approval of immunomodulatory drugs (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertamini, Luca, Bertuglia, Giuseppe, Oliva, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132127/
https://www.ncbi.nlm.nih.gov/pubmed/35646628
http://dx.doi.org/10.3389/fonc.2022.844779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132127/
https://www.ncbi.nlm.nih.gov/pubmed/35646628
http://dx.doi.org/10.3389/fonc.2022.844779

Ejemplares similares